Elizabeth Jean Loan, APRN | |
2201 Lexington Ave, Ashland, KY 41101-2843 | |
(606) 408-4000 | |
Not Available |
Full Name | Elizabeth Jean Loan |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 5 Years |
Location | 2201 Lexington Ave, Ashland, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003434317 | NPI | - | NPPES |
1091208 | Other | KY | RN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WG0000X | Registered Nurse - General Practice | 198028 (Kentucky) | Secondary |
363LF0000X | Nurse Practitioner - Family | 3014609 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
King's Daughters' Medical Center | Ashland, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ashland Hospital Corporation | 7719882521 | 147 |
News Archive
Imagenetix, Inc. (OTC Bulletin Board: IAGXQ), announced today that the Board of Appeals for the United States Patent & Trade Office (USPTO) rejected NIKKEN's effort to invalidate Imagenetix's patent no. 5,569,676 and issued a decision confirming the validity of the patent.
People's bodies respond to exercise in different ways, and their genetic makeup is partly responsible.
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women, according to a study in the May 9 issue of JAMA.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
A new technique for engineering protein crystals is helping scientists figure out the three-dimensional structures of some important biological molecules, including a key plague protein whose structure has eluded researchers until now. The technique, developed with support from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH), promises to help pharmaceutical companies develop more effective drugs to treat various diseases by tailor-making molecules to "fit" a protein's shape.
› Verified 9 days ago
Entity Name | Ashland Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659328250 PECOS PAC ID: 7719882521 Enrollment ID: O20031204000877 |
News Archive
Imagenetix, Inc. (OTC Bulletin Board: IAGXQ), announced today that the Board of Appeals for the United States Patent & Trade Office (USPTO) rejected NIKKEN's effort to invalidate Imagenetix's patent no. 5,569,676 and issued a decision confirming the validity of the patent.
People's bodies respond to exercise in different ways, and their genetic makeup is partly responsible.
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women, according to a study in the May 9 issue of JAMA.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
A new technique for engineering protein crystals is helping scientists figure out the three-dimensional structures of some important biological molecules, including a key plague protein whose structure has eluded researchers until now. The technique, developed with support from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH), promises to help pharmaceutical companies develop more effective drugs to treat various diseases by tailor-making molecules to "fit" a protein's shape.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Elizabeth Jean Loan, APRN Po Box 1595, Ashland, KY 41105-1595 Ph: () - | Elizabeth Jean Loan, APRN 2201 Lexington Ave, Ashland, KY 41101-2843 Ph: (606) 408-4000 |
News Archive
Imagenetix, Inc. (OTC Bulletin Board: IAGXQ), announced today that the Board of Appeals for the United States Patent & Trade Office (USPTO) rejected NIKKEN's effort to invalidate Imagenetix's patent no. 5,569,676 and issued a decision confirming the validity of the patent.
People's bodies respond to exercise in different ways, and their genetic makeup is partly responsible.
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women, according to a study in the May 9 issue of JAMA.
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -; a rare and hard-to-treat cancer.
A new technique for engineering protein crystals is helping scientists figure out the three-dimensional structures of some important biological molecules, including a key plague protein whose structure has eluded researchers until now. The technique, developed with support from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH), promises to help pharmaceutical companies develop more effective drugs to treat various diseases by tailor-making molecules to "fit" a protein's shape.
› Verified 9 days ago
Lisa Ellen Spencer, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Tomie Thompson, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1000 Ashland Dr, Ste G1, Ashland, KY 41101 Phone: 606-833-4043 | |
Susan Aliff, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 520, Ashland, KY 41101 Phone: 606-393-0190 | |
Tracy Ricewick, AGNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 | |
Rita Nicole Fletcher, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 399 Diederich Blvd, Ashland, KY 41101 Phone: 606-324-8060 Fax: 606-325-6889 | |
Darren Barker, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 440, Ashland, KY 41101 Phone: 606-329-2888 | |
Martina Renate Myers, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 Fax: 606-408-6825 |